Pioneering new therapies for cancer

Latest News

MEI Pharma To Present at Two Upcoming Investor Conferences
MEI Pharma Appoints Industry Veteran Frederick W. Driscoll to its Board of Directors
MEI Pharma Interim Data Review Supports Continuation of Clinical Study Evaluating ME-344 in Patients with Breast Cancer
MEI Pharma Reports Second Quarter Fiscal Year 2018 Results